These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1689410)

  • 1. Effects of flestolol, an ultra-short acting beta-adrenoceptor antagonist, on hemodynamic changes produced by treadmill exercise or isoprenaline stimulation in conscious dogs.
    Grohs JG; Fischer G; Raberger G
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):175-81. PubMed ID: 1689410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esmolol: effects on isoprenaline- and exercise-induced cardiovascular stimulation in conscious dogs.
    Fischer G; Grohs JG; Raberger G
    Can J Physiol Pharmacol; 1990 Oct; 68(10):1322-8. PubMed ID: 1981854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of a canine model of transient exercise induced myocardial dysfunction: antianginal effects of flestolol, an ultra short acting beta adrenoceptor antagonist.
    Fischer G; Grohs JG; Raberger G
    Cardiovasc Res; 1990 Feb; 24(2):115-20. PubMed ID: 1970278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled beta-receptor blockade with flestolol: a novel ultrashort-acting beta-blocker.
    Murthy VS; Hwang TF; Rosen LB; Gorczynski RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):72-8. PubMed ID: 2434798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flestolol: an ultra-short-acting beta-adrenergic blocking agent.
    Barton SD; Burge J; Turlapaty P; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A36-A39. PubMed ID: 2870085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic activity of flestolol, a novel ultra-short-acting beta-adrenoceptor antagonist, in the dog.
    Reynolds RD; Brown BS
    Eur J Pharmacol; 1986 Nov; 131(1):55-66. PubMed ID: 2880726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist.
    Achari R; Drissel D; Hulse JD; Bell V; Turlapaty P; Laddu A; Matier WL
    J Clin Pharmacol; 1987 Jan; 27(1):60-4. PubMed ID: 2890664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker.
    Strom J; Josephson M; Frishman WH; Singh B; Heilbrunn S; Osterle S; Turlapaty P; Viray R; Coe J; Bell V
    J Clin Pharmacol; 1988 Mar; 28(3):276-82. PubMed ID: 2896204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and beta-adrenergic blocking activity of flestolol, a short-acting beta blocker.
    Turlapaty P; Burge J; Hulse J; Achari R; Bell V; Mosberg H; Laddu A
    Clin Pharmacol Ther; 1986 May; 39(5):543-9. PubMed ID: 3698462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic and metabolic effects of xamoterol in exercising dogs.
    Fischer G; Schneider W; Grohs JG; Ehrendorfer S; Raberger G
    Eur J Pharmacol; 1990 Feb; 177(1-2):19-27. PubMed ID: 2140326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nitroglycerin on regional myocardial contractile dysfunction produced by treadmill exercise or isoprenaline stimulation in dogs.
    Schneider W; Grohs JG; Krumpl G; Mayer N; Raberger G
    Br J Pharmacol; 1988 Dec; 95(4):1141-50. PubMed ID: 3146399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beta-adrenoceptor antagonism upon delayed reperfusion arrhythmias in conscious dogs.
    Todt H; Krumpl G; Krejcy K; Raberger G
    Eur J Pharmacol; 1991 Apr; 196(2):109-15. PubMed ID: 1678714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
    Daul A; Johnston T; Reher M; Krüger M; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ; Murthy VS; Hwang TF
    J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
    Steinberg JS; Katz RJ; Somberg JC; Keefe D; Laddu AR; Burge J
    Am J Cardiol; 1986 Nov; 58(10):1005-8. PubMed ID: 2877563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
    De Pauw M; Vilaine JP; Heyndrickx GR
    Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.